Last reviewed · How we verify

NCT03190629

The Effect of On-line Hemodiafiltratrion on Nutritional Status and Body Composition

Completed NA Last updated 19 June 2017
What this trial tests

NA trial testing High-flux hemodialysis in Chronic Kidney Disease Requiring Chronic Dialysis in 33 participants. Completed in 31 March 2013.

Timeline
1 April 2012
Primary endpoint
31 March 2013
31 March 2013

Quick facts

Lead sponsorPablo Molina
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment33
Start date1 April 2012
Primary completion31 March 2013
Estimated completion31 March 2013

Drugs / interventions tested

Conditions studied

Sponsor

Pablo Molina

Who can join

18 and older, any sex, with Chronic Kidney Disease Requiring Chronic Dialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compared to conventional hemodialysis (HD), on-line hemodiafiltration (OL-HDF) achieves a more efficient removal of uremic toxins and reduces inflammation, which could favourably affect nutritional status. The aim of this study was to evaluate the 1-year effect of OL-HDF on nutritional status and body composition in prevalent HD patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High-flux hemodialysis

Trials testing the same drug.

Other recruiting trials for Chronic Kidney Disease Requiring Chronic Dialysis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03190629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing